{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:17:34Z","timestamp":1785453454755,"version":"3.56.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"bundesministerium f\u00fcr bildung und forschung","doi-asserted-by":"publisher","award":["01EO1504"],"award-info":[{"award-number":["01EO1504"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008769","name":"Julius-Maximilians-Universit\u00e4t W\u00fcrzburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Arrhythmogenic cardiomyopathy (ACM) is a genetic disease characterized by life-threatening ventricular arrhythmias and sudden cardiac death (SCD) in apparently healthy young adults. Mutations in genes encoding for cellular junctions can be found in about half of the patients. However, disease onset and severity, risk of arrhythmias, and outcome are highly variable and drug-targeted treatment is currently unavailable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>This review focuses on advances in clinical risk stratification, genetic etiology, and pathophysiological concepts. The desmosome is the central part of the disease, but other intercalated disc and associated structural proteins not only broaden the genetic spectrum but also provide novel molecular and cellular insights into the pathogenesis of ACM. Signaling pathways and the role of inflammation will be discussed and targets for novel therapeutic approaches outlined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Genetic discoveries and experimental-driven preclinical research contributed significantly to the understanding of ACM towards mutation- and pathway-specific personalized medicine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11897-021-00532-z","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T20:08:13Z","timestamp":1630699693000},"page":"378-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-8826","authenticated-orcid":false,"given":"Brenda","family":"Gerull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-2343","authenticated-orcid":false,"given":"Andreas","family":"Brodehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"issue":"2","key":"532_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/01.CIR.65.2.384","volume":"65","author":"FI Marcus","year":"1982","unstructured":"Marcus FI, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65(2):384\u201398.","journal-title":"Circulation"},{"issue":"1","key":"532_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJMra1509267","volume":"376","author":"D Corrado","year":"2017","unstructured":"Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61\u201372.","journal-title":"N Engl J Med"},{"issue":"9671","key":"532_CR3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0140-6736(09)60256-7","volume":"373","author":"C Basso","year":"2009","unstructured":"Basso C, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289\u2013300.","journal-title":"Lancet"},{"issue":"13","key":"532_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","volume":"121","author":"FI Marcus","year":"2010","unstructured":"Marcus FI, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533\u201341.","journal-title":"Circulation"},{"issue":"3","key":"532_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/ehjci\/jew229","volume":"18","author":"KH Haugaa","year":"2017","unstructured":"Haugaa KH, et al. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017;18(3):237\u201353.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"532_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","volume":"319","author":"D Corrado","year":"2020","unstructured":"\u2022 Corrado D, et al. Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. Int J Cardiol. 2020;319:106\u201314.. (The aim was to improve the diagnosis of ACM by introducing new diagnostic criteria regarding tissue characterization findings by contrast-enhanced cardiac magnetic resonance, depolarization\/repolarization ECG abnormalities, and ventricular arrhythmia features for the diagnosis of the left ventricular phenotype. The criteria require further validation.)","journal-title":"Int J Cardiol"},{"issue":"5","key":"532_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","volume":"94","author":"C Basso","year":"1996","unstructured":"Basso C, et al. Arrhythmogenic right ventricular cardiomyopathy Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94(5):983\u201391.","journal-title":"Circulation"},{"issue":"4","key":"532_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ajpath.2016.12.018","volume":"187","author":"M Gercek","year":"2017","unstructured":"Gercek M, et al. Cardiomyocyte hypertrophy in arrhythmogenic cardiomyopathy. Am J Pathol. 2017;187(4):752\u201366.","journal-title":"Am J Pathol"},{"issue":"5","key":"532_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCEP.111.964890","volume":"4","author":"A Asimaki","year":"2011","unstructured":"Asimaki A, et al. Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(5):743\u201352.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"25","key":"532_CR10","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","volume":"52","author":"S Sen-Chowdhry","year":"2008","unstructured":"Sen-Chowdhry S, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol. 2008;52(25):2175\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"532_CR11","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","volume":"16","author":"JA Towbin","year":"2019","unstructured":"Towbin JA, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(11):e301\u201372.","journal-title":"Heart Rhythm"},{"issue":"8","key":"532_CR12","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/europace\/euaa105","volume":"22","author":"W Wang","year":"2020","unstructured":"Wang W, et al. Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients. Europace. 2020;22(8):1270\u20138.","journal-title":"Europace"},{"issue":"1","key":"532_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","volume":"42","author":"A Pelliccia","year":"2021","unstructured":"Pelliccia A, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17\u201396.","journal-title":"Eur Heart J"},{"issue":"7","key":"532_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","volume":"54","author":"GM Marcus","year":"2009","unstructured":"Marcus GM, et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol. 2009;54(7):609\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR15","unstructured":"Seferovic, P.M., et al., Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 2019."},{"issue":"7","key":"532_CR16","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.hrthm.2018.01.031","volume":"15","author":"LP Bosman","year":"2018","unstructured":"Bosman LP, et al. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. Heart Rhythm. 2018;15(7):1097\u2013107.","journal-title":"Heart Rhythm"},{"issue":"1","key":"532_CR17","doi-asserted-by":"publisher","first-page":"e008509","DOI":"10.1161\/CIRCEP.120.008509","volume":"14","author":"J Cadrin-Tourigny","year":"2021","unstructured":"\u2022 Cadrin-Tourigny J, et al. Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration. Circ Arrhythm Electrophysiol. 2021;14(1):e008509.. (The article validates criteria to predict life-threatening ventricular arrhythmias in ACM and introduces a novel simple prediction model using only four clinical predictors.)","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"532_CR18","doi-asserted-by":"publisher","first-page":"e002467","DOI":"10.1161\/CIRCGEN.119.002467","volume":"12","author":"FHM van Lint","year":"2019","unstructured":"van Lint FHM, et al. Arrhythmogenic right ventricular cardiomyopathy-associated desmosomal variants are rarely de novo. Circ Genom Precis Med. 2019;12(8):e002467.","journal-title":"Circ Genom Precis Med"},{"key":"532_CR19","doi-asserted-by":"crossref","unstructured":"Brodehl, A., et al., Hemi- and homozygous loss-of-function mutations in DSG2 (desmoglein-2) cause recessive arrhythmogenic cardiomyopathy with an early onset. Int J Mol Sci, 2021. 22(7).","DOI":"10.3390\/ijms22073786"},{"key":"532_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-27371-2_2","volume-title":"Genetic Causes of Cardiac Disease","author":"B Gerull","year":"2019","unstructured":"Gerull B, Klaassen S, Brodehl A. The genetic landscape of cardiomyopathies. In: Genetic Causes of Cardiac Disease. Springer; 2019. p. 45\u201391."},{"key":"532_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fphys.2020.00624","volume":"11","author":"B Gerull","year":"2020","unstructured":"Gerull B, Brodehl A. Genetic animal models for arrhythmogenic cardiomyopathy. Front Physiol. 2020;11:624.","journal-title":"Front Physiol"},{"issue":"2","key":"532_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1006\/dbio.1996.0346","volume":"180","author":"C Bierkamp","year":"1996","unstructured":"Bierkamp C, et al. Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol. 1996;180(2):780\u20135.","journal-title":"Dev Biol"},{"issue":"1","key":"532_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1083\/jcb.135.1.215","volume":"135","author":"P Ruiz","year":"1996","unstructured":"Ruiz P, et al. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol. 1996;135(1):215\u201325.","journal-title":"J Cell Biol"},{"issue":"11","key":"532_CR24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1078\/0171-9335-00278","volume":"81","author":"L Eshkind","year":"2002","unstructured":"Eshkind L, et al. Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur J Cell Biol. 2002;81(11):592\u20138.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"532_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.200402096","volume":"167","author":"KS Grossmann","year":"2004","unstructured":"Grossmann KS, et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol. 2004;167(1):149\u201360.","journal-title":"J Cell Biol"},{"issue":"3","key":"532_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/15419061.2014.906533","volume":"21","author":"DM Patel","year":"2014","unstructured":"Patel DM, Green KJ. Desmosomes in the heart: a review of clinical and mechanistic analyses. Cell Commun Adhes. 2014;21(3):109\u201328.","journal-title":"Cell Commun Adhes"},{"issue":"11","key":"532_CR27","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/ng1461","volume":"36","author":"B Gerull","year":"2004","unstructured":"Gerull B, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2004;36(11):1162\u20134.","journal-title":"Nat Genet"},{"issue":"5","key":"532_CR28","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1086\/344208","volume":"71","author":"A Rampazzo","year":"2002","unstructured":"Rampazzo A, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2002;71(5):1200\u20136.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"532_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCGENETICS.111.961854","volume":"5","author":"F Kirchner","year":"2012","unstructured":"Kirchner F, et al. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations. Circ Cardiovasc Genet. 2012;5(4):400\u201311.","journal-title":"Circ Cardiovasc Genet"},{"issue":"9221","key":"532_CR30","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","volume":"355","author":"G McKoy","year":"2000","unstructured":"McKoy G, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355(9221):2119\u201324.","journal-title":"Lancet"},{"issue":"11","key":"532_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/14779072.2020.1828064","volume":"18","author":"M Leopoulou","year":"2020","unstructured":"Leopoulou M, et al. Naxos disease - a narrative review. Expert Rev Cardiovasc Ther. 2020;18(11):801\u20138.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"532_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yjmcc.2020.03.006","volume":"141","author":"A Brodehl","year":"2020","unstructured":"Brodehl A, et al. A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy. J Mol Cell Cardiol. 2020;141:17\u201329.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"532_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCGENETICS.113.000097","volume":"6","author":"B Gerull","year":"2013","unstructured":"Gerull B, et al. Homozygous founder mutation in desmocollin-2 (DSC2) causes arrhythmogenic cardiomyopathy in the Hutterite population. Circ Cardiovasc Genet. 2013;6(4):327\u201336.","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"532_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1086\/509044","volume":"79","author":"A Heuser","year":"2006","unstructured":"Heuser A, et al. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2006;79(6):1081\u20138.","journal-title":"Am J Hum Genet"},{"key":"532_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.yjmcc.2019.03.014","volume":"129","author":"JD Debus","year":"2019","unstructured":"Debus JD, et al. In vitro analysis of arrhythmogenic cardiomyopathy associated desmoglein-2 (DSG2) mutations reveals diverse glycosylation patterns. J Mol Cell Cardiol. 2019;129:303\u201313.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"532_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/2211-5463.12631","volume":"9","author":"A Brodehl","year":"2019","unstructured":"Brodehl A, et al. Incorporation of desmocollin-2 into the plasma membrane requires N-glycosylation at multiple sites. FEBS Open Bio. 2019;9(5):996\u20131007.","journal-title":"FEBS Open Bio"},{"issue":"26","key":"532_CR37","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1073\/pnas.1606272113","volume":"113","author":"OJ Harrison","year":"2016","unstructured":"Harrison OJ, et al. Structural basis of adhesive binding by desmocollins and desmogleins. Proc Natl Acad Sci U S A. 2016;113(26):7160\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"532_CR38","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/bjd.17388","volume":"180","author":"T Maruthappu","year":"2019","unstructured":"Maruthappu T, et al. Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype. Br J Dermatol. 2019;180(5):1114\u201322.","journal-title":"Br J Dermatol"},{"issue":"1","key":"532_CR39","doi-asserted-by":"publisher","first-page":"e0147641","DOI":"10.1371\/journal.pone.0147641","volume":"11","author":"H Kang","year":"2016","unstructured":"Kang H, et al. Structure of the intermediate filament-binding region of desmoplakin. PLoS One. 2016;11(1):e0147641.","journal-title":"PLoS One"},{"issue":"2","key":"532_CR40","doi-asserted-by":"publisher","first-page":"e003097","DOI":"10.1161\/CIRCGEN.120.003097","volume":"14","author":"A Ghidoni","year":"2021","unstructured":"Ghidoni A, et al. Cadherin 2-related arrhythmogenic cardiomyopathy: prevalence and clinical features. Circ Genom Precis Med. 2021;14(2):e003097.","journal-title":"Circ Genom Precis Med"},{"issue":"3","key":"532_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/15419061.2014.908853","volume":"21","author":"A Vite","year":"2014","unstructured":"Vite A, Radice GL. N-cadherin\/catenin complex as a master regulator of intercalated disc function. Cell Commun Adhes. 2014;21(3):169\u201379.","journal-title":"Cell Commun Adhes"},{"issue":"3","key":"532_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/eurheartj\/ehs373","volume":"34","author":"J van Hengel","year":"2013","unstructured":"van Hengel J, et al. Mutations in the area composita protein alphaT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2013;34(3):201\u201310.","journal-title":"Eur Heart J"},{"issue":"Pt 4","key":"532_CR43","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1242\/jcs.098640","volume":"125","author":"J Li","year":"2012","unstructured":"Li J, et al. Loss of alphaT-catenin alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy and ventricular arrhythmia following acute ischemia. J Cell Sci. 2012;125(Pt 4):1058\u201367.","journal-title":"J Cell Sci"},{"issue":"10","key":"532_CR44","doi-asserted-by":"publisher","first-page":"e002123","DOI":"10.1161\/CIRCGEN.118.002123","volume":"11","author":"M De Bortoli","year":"2018","unstructured":"De Bortoli M, et al. Whole-exome sequencing identifies pathogenic variants in TJP1 gene associated with arrhythmogenic cardiomyopathy. Circ Genom Precis Med. 2018;11(10):e002123.","journal-title":"Circ Genom Precis Med"},{"issue":"9","key":"532_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrm.2016.80","volume":"17","author":"C Zihni","year":"2016","unstructured":"Zihni C, et al. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17(9):564\u201380.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"532_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.semcdb.2014.08.011","volume":"36","author":"CM Van Itallie","year":"2014","unstructured":"Van Itallie CM, Anderson JM. Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol. 2014;36:157\u201365.","journal-title":"Semin Cell Dev Biol"},{"key":"532_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2019.02.004","volume":"208","author":"A Brodehl","year":"2019","unstructured":"Brodehl A, et al. Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathy. Transl Res. 2019;208:15\u201329.","journal-title":"Transl Res"},{"issue":"22","key":"532_CR48","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","volume":"68","author":"MF Ortiz-Genga","year":"2016","unstructured":"Ortiz-Genga MF, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol. 2016;68(22):2440\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"532_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/humu.22942","volume":"37","author":"A Brodehl","year":"2016","unstructured":"Brodehl A, et al. Mutations in FLNC are associated with familial restrictive cardiomyopathy. Hum Mutat. 2016;37(3):269\u201379.","journal-title":"Hum Mutat"},{"key":"532_CR50","doi-asserted-by":"crossref","unstructured":"Protonotarios, A., et al., The novel desmin variant p.Leu115Ile is associated with a unique form of biventricular arrhythmogenic cardiomyopathy. Can J Cardiol, 2020.","DOI":"10.1016\/j.cjca.2020.11.017"},{"issue":"15","key":"532_CR51","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/CIRCULATIONAHA.117.028719","volume":"137","author":"FJ Bermudez-Jimenez","year":"2018","unstructured":"Bermudez-Jimenez FJ, et al. Novel desmin mutation p.Glu401Asp impairs filament formation, disrupts cell membrane integrity, and causes severe arrhythmogenic left ventricular cardiomyopathy\/dysplasia. Circulation. 2018;137(15):1595\u2013610.","journal-title":"Circulation"},{"issue":"23","key":"532_CR52","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1093\/hmg\/ddq387","volume":"19","author":"B Klauke","year":"2010","unstructured":"Klauke B, et al. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Genet. 2010;19(23):4595\u2013607.","journal-title":"Hum Mol Genet"},{"issue":"22","key":"532_CR53","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1161\/CIRCULATIONAHA.120.050218","volume":"142","author":"H Herrmann","year":"2020","unstructured":"Herrmann H, et al. Dual functional states of R406W-desmin assembly complexes cause cardiomyopathy with severe intercalated disc derangement in humans and in knock-in mice. Circulation. 2020;142(22):2155\u201371.","journal-title":"Circulation"},{"issue":"2","key":"532_CR54","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/mgg3.358","volume":"6","author":"I Schirmer","year":"2018","unstructured":"Schirmer I, et al. A novel desmin (DES) indel mutation causes severe atypical cardiomyopathy in combination with atrioventricular block and skeletal myopathy. Mol Genet Genomic Med. 2018;6(2):288\u201393.","journal-title":"Mol Genet Genomic Med"},{"issue":"19","key":"532_CR55","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1074\/jbc.M111.313841","volume":"287","author":"A Brodehl","year":"2012","unstructured":"Brodehl A, et al. Dual color photoactivation localization microscopy of cardiomyopathy-associated desmin mutants. J Biol Chem. 2012;287(19):16047\u201357.","journal-title":"J Biol Chem"},{"issue":"1","key":"532_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.hrcr.2019.10.001","volume":"6","author":"JM Good","year":"2020","unstructured":"Good JM, et al. ACTN2 variant associated with a cardiac phenotype suggestive of left-dominant arrhythmogenic cardiomyopathy. HeartRhythm Case Rep. 2020;6(1):15\u20139.","journal-title":"HeartRhythm Case Rep"},{"issue":"2","key":"532_CR57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/cge.12458","volume":"88","author":"JM Lopez-Ayala","year":"2015","unstructured":"Lopez-Ayala JM, et al. A mutation in the Z-line Cypher\/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathy. Clin Genet. 2015;88(2):172\u20136.","journal-title":"Clin Genet"},{"issue":"7","key":"532_CR58","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/europace\/eun030","volume":"10","author":"S Peters","year":"2008","unstructured":"Peters S. Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: clues from long-term follow-up. Europace. 2008;10(7):816\u201320.","journal-title":"Europace"},{"issue":"3","key":"532_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/hmg\/10.3.189","volume":"10","author":"N Tiso","year":"2001","unstructured":"Tiso N, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10(3):189\u201394.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"532_CR60","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA van der Zwaag","year":"2012","unstructured":"van der Zwaag PA, et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail. 2012;14(11):1199\u2013207.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"532_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/CIRCEP.107.748103","volume":"1","author":"E Delpon","year":"2008","unstructured":"Delpon E, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol. 2008;1(3):209\u201318.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"532_CR62","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(95)90359-3","volume":"80","author":"Q Wang","year":"1995","unstructured":"Wang Q, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80(5):805\u201311.","journal-title":"Cell"},{"issue":"1","key":"532_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/cvr\/cvw234","volume":"113","author":"AS Te Riele","year":"2017","unstructured":"Te Riele AS, et al. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis. Cardiovasc Res. 2017;113(1):102\u201311.","journal-title":"Cardiovasc Res"},{"issue":"18","key":"532_CR64","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","volume":"36","author":"J Haas","year":"2015","unstructured":"Haas J, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J. 2015;36(18):1123\u201335.","journal-title":"Eur Heart J"},{"key":"532_CR65","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3389\/fphys.2018.01372","volume":"9","author":"W Li","year":"2018","unstructured":"Li W, et al. SCN5A variants: association with cardiac disorders. Front Physiol. 2018;9:1372.","journal-title":"Front Physiol"},{"issue":"1","key":"532_CR66","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cell.2019.11.041","volume":"180","author":"D Jiang","year":"2020","unstructured":"Jiang D, et al. Structure of the cardiac sodium channel. Cell. 2020;180(1):122-134 e10.","journal-title":"Cell"},{"issue":"4","key":"532_CR67","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1152\/physrev.00002.2005","volume":"85","author":"JM Nerbonne","year":"2005","unstructured":"Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev. 2005;85(4):1205\u201353.","journal-title":"Physiol Rev"},{"key":"532_CR68","doi-asserted-by":"crossref","unstructured":"Peng, W., et al., Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2. Science, 2016. 354(6310).","DOI":"10.1126\/science.aah5324"},{"issue":"4","key":"532_CR69","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1152\/physrev.1998.78.4.921","volume":"78","author":"HK Simmerman","year":"1998","unstructured":"Simmerman HK, Jones LR. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev. 1998;78(4):921\u201347.","journal-title":"Physiol Rev"},{"issue":"2","key":"532_CR70","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41556-020-00630-5","volume":"23","author":"A Karoutas","year":"2021","unstructured":"Karoutas A, Akhtar A. Functional mechanisms and abnormalities of the nuclear lamina. Nat Cell Biol. 2021;23(2):116\u201326.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"532_CR71","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1742-4658.2007.05694.x","volume":"274","author":"JM Bridger","year":"2007","unstructured":"Bridger JM, et al. The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS J. 2007;274(6):1354\u201361.","journal-title":"FEBS J"},{"issue":"9","key":"532_CR72","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","volume":"33","author":"G Quarta","year":"2012","unstructured":"Quarta G, et al. Mutations in the Lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2012;33(9):1128\u201336.","journal-title":"Eur Heart J"},{"key":"532_CR73","doi-asserted-by":"crossref","unstructured":"Maggi, L., et al., Skeletal and cardiac muscle disorders caused by mutations in genes encoding intermediate filament proteins. Int J Mol Sci, 2021. 22(8).","DOI":"10.3390\/ijms22084256"},{"issue":"7","key":"532_CR74","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/humu.22793","volume":"36","author":"TP Alastalo","year":"2015","unstructured":"Alastalo TP, et al. LMNA Mutation c.917T>G (p.L306R) leads to deleterious hyper-assembly of Lamin A\/C and associates with severe right ventricular cardiomyopathy and premature aging. Hum Mutat. 2015;36(7):694\u2013703.","journal-title":"Hum Mutat"},{"issue":"7","key":"532_CR75","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/ajmg.a.35971","volume":"161A","author":"MS Kane","year":"2013","unstructured":"Kane MS, et al. LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset. Am J Med Genet A. 2013;161A(7):1599\u2013611.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"532_CR76","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","volume":"82","author":"ND Merner","year":"2008","unstructured":"Merner ND, et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 2008;82(4):809\u201321.","journal-title":"Am J Hum Genet"},{"key":"532_CR77","doi-asserted-by":"crossref","unstructured":"Jang, M.W., et al., A nonsense TMEM43 variant leads to disruption of connexin-linked function and autosomal dominant auditory neuropathy spectrum disorder. Proc Natl Acad Sci U S A, 2021. 118(22).","DOI":"10.1073\/pnas.2019681118"},{"issue":"14","key":"532_CR78","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.119.040366","volume":"140","author":"L Padron-Barthe","year":"2019","unstructured":"\u2022 Padron-Barthe L, et al. Severe cardiac dysfunction and death caused by arrhythmogenic right ventricular cardiomyopathy type 5 are improved by inhibition of glycogen synthase kinase-3beta. Circulation. 2019;140(14):1188\u2013204.. (The study shows that overexpression of calcineurin A\u03b21 in TMEM43-S358L mutant mice or chemical GSK3\u03b2 inhibition improves cardiac function and increases mice life span and suggests the glycogen synthase as a new therapeutic target.)","journal-title":"Circulation"},{"issue":"3","key":"532_CR79","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx205","volume":"114","author":"MJ Stroud","year":"2018","unstructured":"Stroud MJ, et al. Luma is not essential for murine cardiac development and function. Cardiovasc Res. 2018;114(3):378\u201388.","journal-title":"Cardiovasc Res"},{"issue":"Suppl_1","key":"532_CR80","first-page":"A15878","volume":"138","author":"M Zink","year":"2018","unstructured":"Zink M, et al. Decreased survival and cardiac performance of mutant TMEM43 in transgenic zebrafish. Circulation. 2018;138(Suppl_1):A15878\u2013A15878.","journal-title":"Circulation"},{"key":"532_CR81","doi-asserted-by":"publisher","first-page":"101957","DOI":"10.1016\/j.scr.2020.101957","volume":"48","author":"S Ratnavadivel","year":"2020","unstructured":"Ratnavadivel S, et al. Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p S358L. Stem Cell Res. 2020;48:101957.","journal-title":"Stem Cell Res"},{"issue":"2","key":"532_CR82","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jacbts.2018.12.001","volume":"4","author":"N Abdelfatah","year":"2019","unstructured":"Abdelfatah N, et al. Characterization of a unique form of arrhythmic cardiomyopathy caused by recessive mutation in LEMD2. JACC Basic Transl Sci. 2019;4(2):204\u201321.","journal-title":"JACC Basic Transl Sci"},{"issue":"Pt 24","key":"532_CR83","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1242\/jcs.02701","volume":"118","author":"A Brachner","year":"2005","unstructured":"Brachner A, et al. LEM2 is a novel MAN1-related inner nuclear membrane protein associated with A-type lamins. J Cell Sci. 2005;118(Pt 24):5797\u2013810.","journal-title":"J Cell Sci"},{"issue":"4","key":"532_CR84","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajhg.2019.02.021","volume":"104","author":"F Marbach","year":"2019","unstructured":"Marbach F, et al. The discovery of a LEMD2-associated nuclear envelopathy with early progeroid appearance suggests advanced applications for AI-driven facial phenotyping. Am J Hum Genet. 2019;104(4):749\u201357.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"532_CR85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12968-020-00702-3","volume":"23","author":"T Zghaib","year":"2021","unstructured":"Zghaib T, et al. Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: prevalence, patterns, and association with arrhythmias. J Cardiovasc Magn Reson. 2021;23(1):58.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"532_CR86","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jacc.2004.09.053","volume":"45","author":"H Tandri","year":"2005","unstructured":"Tandri H, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005;45(1):98\u2013103.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"532_CR87","doi-asserted-by":"publisher","first-page":"e0174019","DOI":"10.1371\/journal.pone.0174019","volume":"12","author":"A Brodehl","year":"2017","unstructured":"Brodehl A, et al. Transgenic mice overexpressing desmocollin-2 (DSC2) develop cardiomyopathy associated with myocardial inflammation and fibrotic remodeling. PLoS One. 2017;12(3):e0174019.","journal-title":"PLoS One"},{"issue":"6","key":"532_CR88","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11886-021-01488-1","volume":"23","author":"C Grigoratos","year":"2021","unstructured":"Grigoratos C, Aquaro GD. The role of cardiovascular magnetic resonance in ARVC. Curr Cardiol Rep. 2021;23(6):56.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"532_CR89","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ehjci\/jez277","volume":"21","author":"D Segura-Rodriguez","year":"2020","unstructured":"Segura-Rodriguez D, et al. Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study. Eur Heart J Cardiovasc Imaging. 2020;21(4):378\u201386.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"22","key":"532_CR90","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1093\/eurheartj\/ehn415","volume":"29","author":"C Basso","year":"2008","unstructured":"Basso C, et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J. 2008;29(22):2760\u201371.","journal-title":"Eur Heart J"},{"issue":"4","key":"532_CR91","doi-asserted-by":"publisher","first-page":"e94820","DOI":"10.1371\/journal.pone.0094820","volume":"9","author":"JM Gho","year":"2014","unstructured":"Gho JM, et al. High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy. PLoS One. 2014;9(4):e94820.","journal-title":"PLoS One"},{"issue":"12","key":"532_CR92","doi-asserted-by":"publisher","first-page":"153269","DOI":"10.1016\/j.prp.2020.153269","volume":"216","author":"G Mansueto","year":"2020","unstructured":"Mansueto G, et al. Autoptic findings of sudden cardiac death (SCD) in patients with arrhythmogenic ventricular cardiomiopathy (AVC) from left ventricle and biventricular involvement. Pathol Res Pract. 2020;216(12):153269.","journal-title":"Pathol Res Pract"},{"key":"532_CR93","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphys.2020.00279","volume":"11","author":"AS Maione","year":"2020","unstructured":"Maione AS, et al. Fibrosis in arrhythmogenic cardiomyopathy: the phantom thread in the fibro-adipose tissue. Front Physiol. 2020;11:279.","journal-title":"Front Physiol"},{"issue":"3","key":"532_CR94","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/cvr\/cvw259","volume":"113","author":"SH Vermij","year":"2017","unstructured":"Vermij SH, Abriel H, van Veen TA. Refining the molecular organization of the cardiac intercalated disc. Cardiovasc Res. 2017;113(3):259\u201375.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"532_CR95","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jvc.2011.03.002","volume":"13","author":"EM Oxford","year":"2011","unstructured":"Oxford EM, et al. Ultrastructural changes in cardiac myocytes from Boxer dogs with arrhythmogenic right ventricular cardiomyopathy. J Vet Cardiol. 2011;13(2):101\u201313.","journal-title":"J Vet Cardiol"},{"issue":"3","key":"532_CR96","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.hrthm.2012.11.018","volume":"10","author":"M Noorman","year":"2013","unstructured":"Noorman M, et al. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm. 2013;10(3):412\u20139.","journal-title":"Heart Rhythm"},{"key":"532_CR97","doi-asserted-by":"crossref","unstructured":"Maione, A.S., et al., Excess TGF-beta1 drives cardiac mesenchymal stromal cells to a pro-fibrotic commitment in arrhythmogenic cardiomyopathy. Int J Mol Sci, 2021. 22(5).","DOI":"10.3390\/ijms22052673"},{"issue":"4","key":"532_CR98","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.201507018","volume":"212","author":"AD Dubash","year":"2016","unstructured":"Dubash AD, et al. Plakophilin-2 loss promotes TGF-beta1\/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes. J Cell Biol. 2016;212(4):425\u201338.","journal-title":"J Cell Biol"},{"issue":"2","key":"532_CR99","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s13238-018-0563-2","volume":"10","author":"G Zheng","year":"2019","unstructured":"Zheng G, et al. TMEM43-S358L mutation enhances NF-kappaB-TGFbeta signal cascade in arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Protein Cell. 2019;10(2):104\u201319.","journal-title":"Protein Cell"},{"issue":"2","key":"532_CR100","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cardiores.2004.10.005","volume":"65","author":"G Beffagna","year":"2005","unstructured":"Beffagna G, et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 2005;65(2):366\u201373.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"532_CR101","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41569-019-0200-7","volume":"16","author":"KM Austin","year":"2019","unstructured":"Austin KM, et al. Molecular mechanisms of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2019;16(9):519\u201337.","journal-title":"Nat Rev Cardiol"},{"key":"532_CR102","doi-asserted-by":"crossref","unstructured":"Muccioli, S., et al., From channels to canonical Wnt signaling: a pathological perspective. Int J Mol Sci, 2021. 22(9).","DOI":"10.3390\/ijms22094613"},{"issue":"36","key":"532_CR103","doi-asserted-by":"publisher","first-page":"60640","DOI":"10.18632\/oncotarget.17457","volume":"8","author":"A Lorenzon","year":"2017","unstructured":"Lorenzon A, et al. Wnt\/beta-catenin pathway in arrhythmogenic cardiomyopathy. Oncotarget. 2017;8(36):60640\u201355.","journal-title":"Oncotarget"},{"issue":"7","key":"532_CR104","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1172\/JCI27751","volume":"116","author":"E Garcia-Gras","year":"2006","unstructured":"Garcia-Gras E, et al. Suppression of canonical Wnt\/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest. 2006;116(7):2012\u201321.","journal-title":"J Clin Invest"},{"issue":"12","key":"532_CR105","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1161\/CIRCRESAHA.111.255075","volume":"109","author":"R Lombardi","year":"2011","unstructured":"Lombardi R, et al. Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res. 2011;109(12):1342\u201353.","journal-title":"Circ Res"},{"issue":"11","key":"532_CR106","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJMoa0808138","volume":"360","author":"A Asimaki","year":"2009","unstructured":"Asimaki A, et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2009;360(11):1075\u201384.","journal-title":"N Engl J Med"},{"issue":"2","key":"532_CR107","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cvr\/cvv270","volume":"109","author":"S Kant","year":"2016","unstructured":"Kant S, et al. Loss of plakoglobin immunoreactivity in intercalated discs in arrhythmogenic right ventricular cardiomyopathy: protein mislocalization versus epitope masking. Cardiovasc Res. 2016;109(2):260\u201371.","journal-title":"Cardiovasc Res"},{"issue":"240","key":"532_CR108","doi-asserted-by":"publisher","first-page":"240ra74","DOI":"10.1126\/scitranslmed.3008008","volume":"6","author":"A Asimaki","year":"2014","unstructured":"Asimaki A, et al. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. Sci Transl Med. 2014;6(240):240ra74.","journal-title":"Sci Transl Med"},{"issue":"8","key":"532_CR109","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/cvr\/cvy057","volume":"114","author":"A Giuliodori","year":"2018","unstructured":"Giuliodori A, et al. Loss of cardiac Wnt\/beta-catenin signalling in desmoplakin-deficient AC8 zebrafish models is rescuable by genetic and pharmacological intervention. Cardiovasc Res. 2018;114(8):1082\u201397.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"532_CR110","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/CIRCRESAHA.114.302810","volume":"114","author":"SN Chen","year":"2014","unstructured":"Chen SN, et al. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. Circ Res. 2014;114(3):454\u201368.","journal-title":"Circ Res"},{"key":"532_CR111","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, et al. The hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604.","journal-title":"Annu Rev Biochem"},{"key":"532_CR112","doi-asserted-by":"crossref","unstructured":"Rouhi, L., et al., The EP300\/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure. Cardiovasc Res, 2021.","DOI":"10.1093\/cvr\/cvab197"},{"key":"532_CR113","doi-asserted-by":"crossref","unstructured":"Shoykhet, M., et al., Cardiomyocyte adhesion and hyperadhesion differentially require ERK1\/2 and plakoglobin. JCI Insight, 2020. 5(18).","DOI":"10.1172\/jci.insight.140066"},{"issue":"6","key":"532_CR114","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1111\/jcmm.16388","volume":"25","author":"ZJ van der Klooster","year":"2021","unstructured":"van der Klooster ZJ, et al. P62-positive aggregates are homogenously distributed in the myocardium and associated with the type of mutation in genetic cardiomyopathy. J Cell Mol Med. 2021;25(6):3160\u20136.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"532_CR115","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2143\/AC.60.5.2004965","volume":"60","author":"K Yamaji","year":"2005","unstructured":"Yamaji K, et al. Apoptotic myocardial cell death in the setting of arrhythmogenic right ventricular cardiomyopathy. Acta Cardiol. 2005;60(5):465\u201370.","journal-title":"Acta Cardiol"},{"issue":"2","key":"532_CR116","first-page":"479","volume":"152","author":"M Valente","year":"1998","unstructured":"Valente M, et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol. 1998;152(2):479\u201384.","journal-title":"Am J Pathol"},{"issue":"8","key":"532_CR117","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1084\/jem.20090641","volume":"206","author":"K Pilichou","year":"2009","unstructured":"Pilichou K, et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med. 2009;206(8):1787\u2013802.","journal-title":"J Exp Med"},{"issue":"9","key":"532_CR118","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.amjcard.2008.06.054","volume":"102","author":"B Bauce","year":"2008","unstructured":"Bauce B, et al. Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. Am J Cardiol. 2008;102(9):1252\u20137.","journal-title":"Am J Cardiol"},{"key":"532_CR119","doi-asserted-by":"publisher","first-page":"9583268","DOI":"10.1155\/2016\/9583268","volume":"2016","author":"P Xia","year":"2016","unstructured":"Xia P, Liu Y, Cheng Z. Signaling pathways in cardiac myocyte apoptosis. Biomed Res Int. 2016;2016:9583268.","journal-title":"Biomed Res Int"},{"issue":"22","key":"532_CR120","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1053\/euhj.1999.1548","volume":"20","author":"SA Cook","year":"1999","unstructured":"Cook SA, Poole-Wilson PA. Cardiac myocyte apoptosis. Eur Heart J. 1999;20(22):1619\u201329.","journal-title":"Eur Heart J"},{"issue":"4","key":"532_CR121","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239\u201357.","journal-title":"Br J Cancer"},{"issue":"16","key":"532_CR122","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJM199610173351604","volume":"335","author":"Z Mallat","year":"1996","unstructured":"Mallat Z, et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335(16):1190\u20136.","journal-title":"N Engl J Med"},{"key":"532_CR123","doi-asserted-by":"crossref","unstructured":"Piriou, N., et al., Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies. ESC Heart Fail, 2020.","DOI":"10.1002\/ehf2.12686"},{"issue":"2","key":"532_CR124","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.ijcard.2011.09.017","volume":"157","author":"AP Patrianakos","year":"2012","unstructured":"Patrianakos AP, et al. Arrhythmogenic right ventricular cardiomyopathy\/dysplasia and troponin release Myocarditis or the \u201chot phase\u201d of the disease? Int J Cardiol. 2012;157(2):e26-8.","journal-title":"Int J Cardiol"},{"key":"532_CR125","doi-asserted-by":"crossref","unstructured":"\u2022 Smith, E.D., et al., Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation, 2020. (The article highlights a distinct form of DSP-related cardiomyopathy characterized by episodic myocardial injury, left ventricular fibrosis that precedes systolic dysfunction, and a high incidence of ventricular arrhythmias.)","DOI":"10.1161\/CIRCULATIONAHA.119.044934"},{"issue":"10","key":"532_CR126","doi-asserted-by":"publisher","first-page":"e015289","DOI":"10.1161\/JAHA.119.015289","volume":"9","author":"W Poller","year":"2020","unstructured":"Poller W, et al. Familial recurrent myocarditis triggered by exercise in patients with a truncating variant of the desmoplakin gene. J Am Heart Assoc. 2020;9(10):e015289.","journal-title":"J Am Heart Assoc"},{"issue":"44","key":"532_CR127","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","volume":"39","author":"D Chatterjee","year":"2018","unstructured":"Chatterjee D, et al. An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis. Eur Heart J. 2018;39(44):3932\u201344.","journal-title":"Eur Heart J"},{"issue":"15","key":"532_CR128","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.119.043931","volume":"141","author":"ALP Caforio","year":"2020","unstructured":"\u2022 Caforio ALP, et al. Evidence from family studies for autoimmunity in arrhythmogenic right ventricular cardiomyopathy: associations of circulating anti-heart and anti-intercalated disk autoantibodies with disease severity and family history. Circulation. 2020;141(15):1238\u201348.. (The paper shows evidence of autoimmunity via anti-heart autoantibodies and anti-intercalated disk autoantibodies in the majority of familial and in almost half of sporadic ACM patients. Antibodies in probands and affected relatives were associated with features of disease severity.)","journal-title":"Circulation"},{"issue":"23","key":"532_CR129","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1093\/hmg\/ddr392","volume":"20","author":"D Li","year":"2011","unstructured":"Li D, et al. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. Hum Mol Genet. 2011;20(23):4582\u201396.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"532_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00395-020-0803-5","volume":"115","author":"N Lubos","year":"2020","unstructured":"Lubos N, et al. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115(4):42.","journal-title":"Basic Res Cardiol"},{"issue":"18","key":"532_CR131","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCULATIONAHA.119.040676","volume":"140","author":"SP Chelko","year":"2019","unstructured":"\u2022 Chelko SP, et al. Therapeutic modulation of the immune response in arrhythmogenic cardiomyopathy. Circulation. 2019;140(18):1491\u2013505.. (It shows that inflammatory signaling plays a major role in ACM and drives key features of the disease. Targeting inflammatory pathways may be an effective therapy for ACM.)","journal-title":"Circulation"},{"issue":"12","key":"532_CR132","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"4","key":"532_CR133","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cvr\/cvs219","volume":"95","author":"S Rizzo","year":"2012","unstructured":"Rizzo S, et al. Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res. 2012;95(4):409\u201318.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"532_CR134","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41467-017-00127-0","volume":"8","author":"M Cerrone","year":"2017","unstructured":"Cerrone M, et al. Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm. Nat Commun. 2017;8(1):106.","journal-title":"Nat Commun"},{"key":"532_CR135","doi-asserted-by":"crossref","unstructured":"van Opbergen, C.J.M., et al., Plakophilin-2 haploinsufficiency causes calcium handling deficits and modulates the cardiac response towards stress. Int J Mol Sci, 2019. 20(17).","DOI":"10.3390\/ijms20174076"},{"issue":"4","key":"532_CR136","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.hrthm.2016.12.010","volume":"14","author":"S Ermakov","year":"2017","unstructured":"Ermakov S, et al. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2017;14(4):564\u20139.","journal-title":"Heart Rhythm"},{"issue":"11","key":"532_CR137","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.hrthm.2011.06.029","volume":"8","author":"M Deo","year":"2011","unstructured":"Deo M, et al. Relative contribution of changes in sodium current versus intercellular coupling on reentry initiation in 2-dimensional preparations of plakophilin-2-deficient cardiac cells. Heart Rhythm. 2011;8(11):1740\u20138.","journal-title":"Heart Rhythm"},{"key":"532_CR138","doi-asserted-by":"crossref","unstructured":"\u2022 Shiba, M., et al., Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes. Hum Mol Genet, 2021. (The article provides evidence that adeno-associated virus-mediated replacement of DSG2 in mutant (R119X) iPSC-derived cardiomyocytes significantly recovers cardiomyocyte contraction force.)","DOI":"10.1093\/hmg\/ddab127"},{"issue":"6","key":"532_CR139","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1172\/JCI136873","volume":"130","author":"F Chemello","year":"2020","unstructured":"Chemello F, Bassel-Duby R, Olson EN. Correction of muscular dystrophies by CRISPR gene editing. J Clin Invest. 2020;130(6):2766\u201376.","journal-title":"J Clin Invest"},{"key":"532_CR140","doi-asserted-by":"crossref","unstructured":"Chemello, F., et al., Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing. Sci Adv, 2021. 7(18).","DOI":"10.1126\/sciadv.abg4910"},{"issue":"6271","key":"532_CR141","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long C, et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science. 2016;351(6271):400\u20133.","journal-title":"Science"},{"key":"532_CR142","doi-asserted-by":"crossref","unstructured":"Olson, E.N., Toward the correction of muscular dystrophy by gene editing. Proc Natl Acad Sci U S A, 2021. 118(22).","DOI":"10.1073\/pnas.2004840117"},{"issue":"6096","key":"532_CR143","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816\u201321.","journal-title":"Science"},{"issue":"2","key":"532_CR144","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41596-020-00450-9","volume":"16","author":"TP Huang","year":"2021","unstructured":"Huang TP, Newby GA, Liu DR. Precision genome editing using cytosine and adenine base editors in mammalian cells. Nat Protoc. 2021;16(2):1089\u2013128.","journal-title":"Nat Protoc"},{"issue":"3","key":"532_CR145","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","volume":"173","author":"S Konermann","year":"2018","unstructured":"Konermann S, et al. Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell. 2018;173(3):665-676 e14.","journal-title":"Cell"},{"issue":"8","key":"532_CR146","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1172\/JCI125538","volume":"129","author":"JD Roberts","year":"2019","unstructured":"\u2022 Roberts JD, et al. Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. J Clin Invest. 2019;129(8):3171\u201384.. (The article introduces a new pathway for ACM\u2014the role of ankyrin-B in cardiac structure and signaling. They provide a molecular link between ankyrin-B and \u03b2-catenin and show evidence for targeted activation of the WNT\/\u03b2-catenin pathway as a potential treatment for this disease.)","journal-title":"J Clin Invest"},{"key":"532_CR147","doi-asserted-by":"crossref","unstructured":"Chelko, S.P., et al., Central role for GSK3beta in the pathogenesis of arrhythmogenic cardiomyopathy. JCI Insight, 2016. 1(5).","DOI":"10.1172\/jci.insight.85923"},{"issue":"3","key":"532_CR148","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/pace.14153","volume":"44","author":"G Peretto","year":"2021","unstructured":"Peretto G, et al. Immunosuppressive therapy in childhood-onset arrhythmogenic inflammatory cardiomyopathy. Pacing Clin Electrophysiol. 2021;44(3):552\u20136.","journal-title":"Pacing Clin Electrophysiol"},{"key":"532_CR149","doi-asserted-by":"crossref","unstructured":"Schinner, C., et al., Stabilization of desmoglein-2 binding rescues arrhythmia in arrhythmogenic cardiomyopathy. JCI Insight, 2020. 5(9).","DOI":"10.1172\/jci.insight.130141"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-021-00532-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-021-00532-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-021-00532-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T07:21:40Z","timestamp":1675668100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-021-00532-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":149,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1007\/s11897-021-00532-z","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"9 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated due to the insertion of Open Access funding note.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}